W. Timothy Garvey
-
- Diabetes Treatment and Management 44
- Diabetes, Cardiovascular Risks, and Lipoproteins 20
- Pharmacy top 0.05%
- Obesity and Health Practices 15
- Physiology top 0.2%
- Diet and metabolism studies 39
- Adipose Tissue and Metabolism 16
- Pharmacology top 0.1%
- Pharmacology and Obesity Treatment 44
- Endocrine and Autonomic Systems top 0.5%
-
- Metabolism, Diabetes, and Cancer 35
-
- Bariatric Surgery and Outcomes 15
- Co-authors
- Daniel L. HurleyJeffrey I. MechanickCristina Lara‐CastroPenny WallaceRobert F. KushnerRichard L. KleinAlan J. GarberAdrienne Youdim
- Journals
- New England Journal of Medicine (2 papers)JAMA (1 paper)Journal of Clinical Investigation (3 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
W. Timothy Garvey
158 papers receiving 13.9k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Endocrinology, Diabetes and Metabolism 5.6k
- Pharmacy 1.1k
- Physiology 5.1k
- Pharmacology 3.3k
- Endocrine and Autonomic Systems 1.2k
Countries citing papers authored by W. Timothy Garvey
This map shows the geographic impact of W. Timothy Garvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Timothy Garvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Timothy Garvey more than expected).
Fields of papers citing papers by W. Timothy Garvey
This network shows the impact of papers produced by W. Timothy Garvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Timothy Garvey. The network helps show where W. Timothy Garvey may publish in the future.
Co-authorship network
The 25 scholars most cited alongside W. Timothy Garvey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2023 | 31 | |
| 5 | 2023 | 25 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 0 | |
| 9 | Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trialbreakdown → | 2022 | 469 |
| 10 | 2021 | 4 | |
| 11 | 2020 | 139 | |
| 12 | Illuminating the Roles of Outer Membrane Proteins and Outer Membrane Vesicles in Vibrio Cholerae Biofilm | 2019 | 1 |
| 13 | 2016 | 40 | |
| 14 | 2015 | 87 | |
| 15 | 2015 | 7 | |
| 16 | 2014 | 100 | |
| 17 | Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension studybreakdown → | 2011 | 501 |
| 18 | 2010 | 55 | |
| 19 | 2001 | 202 | |
| 20 | 1998 | 146 |
About W. Timothy Garvey
W. Timothy Garvey is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacy and Pharmacology, having authored 164 papers that have together received 14.4k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (44 papers), Pharmacology and Obesity Treatment (44 papers), Diet and metabolism studies (39 papers), Metabolism, Diabetes, and Cancer (35 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers), Adipose Tissue and Metabolism (16 papers), Bariatric Surgery and Outcomes (15 papers) and Obesity and Health Practices (15 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (5.6k citations), Pharmacy (1.1k citations) and Physiology (5.1k citations). W. Timothy Garvey has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Daniel L. Hurley, Jeffrey I. Mechanick, Cristina Lara‐Castro, Penny Wallace, Robert F. Kushner, Richard L. Klein, Alan J. Garber, Adrienne Youdim, Ted D. Adams and John B. Dixon. Their work appears in journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.